Niraj Nag

About

Dynamic and highly skilled Postdoctoral Research Fellow based in Chicago, specializing in cancer biology and microbiology, with special emphasis on protein biochemistry. Proficient in handling animal models (mice and rabbits) & clinical samples. Experienced in confocal, fixed, & live-cell imaging, western blotting, flow cytometry, protein purification & receptor-induced kinase signalling. Recognized for meticulous experimental design, data interpretation, & effective communication. With a team-oriented mindset, I am dedicated to driving industrial innovation & scientific discovery in translational oncology, microbiology & immunology research.

Specialization:
Receptor-mediated Targeted Drug Therapy, Translational Oncology, Preclinical Cancer Models, Microbial Proteases, Protein Purification, & Microbiology

Employment

• University of Illinois Chicago Post Doctoral Research Associate
  2025 - Present
• National Institute of Cholera and Enteric Diseases Senior Research Fellow
  2018 - Present
• National Institute of Technology Rourkela JUNIOR RESEARCH FELLOW
  2017 - 2018
• Chittaranjan National Cancer Institute RESEARCH FELLOW
  2015 - 2016

Education

• University of Calcutta Master in Science
  2012 - 2014

Projects & Funding

Projects & funding information is unavailable.

Publications (8)

• Microtubule disruption and apoptotic induction by Vibrio cholerae haemagglutinin protease: Implications for anticancer therapy in colon and gastric tumours
  The Indian Journal of Medical Research 2026 DOI: 10.25259/ijmr_189_2026
  +Save
• Mixed lineage kinase 3 mediates SARS‐CoV‐2‐induced kidney injury via the Hsp70‐IL‐17A axis
  Interdisciplinary Medicine 2026 DOI: 10.1002/inmd.70154
  +Save
• A peptide-induced regression of low-grade malignant breast tumor via activation of autophagy in breast cancer cells
  Molecular Medicine 2026 DOI: 10.1186/s10020-026-01514-4
  +Save
• MAP4K4 regulates the immune landscape of pancreatic tumor microenvironment and provides an opportunity for immunotherapy
  Cancer Letters 2026 DOI: 10.1016/j.canlet.2026.218336
  +Save
• Therapeutic effect of microbial proteases in protease-activated receptor (PARs) induced apoptosis in ovarian cancer cells
  2024
  +Save
• Dysregulated Cholesterol Metabolism with Anomalous PI3K/Akt/mTOR pathway Predicts Poor Carboplatin Response in High Grade Serous Ovarian Cancer
  2024 DOI: 10.1101/2024.08.17.608375
  +Save
• Metallo-protease Peptidase M84 from Bacillus altitudinis induces ROS-dependent apoptosis in ovarian cancer cells by targeting PAR-1
  iScience 2024 DOI: 10.1016/j.isci.2024.109828
  +Save
• Xanthone from Swertia chirata Exerts Chemotherapeutic Potential Against Colon Carcinoma
  Current Science 2022 DOI: 10.18520/cs/v122/i1/47-55
  +Save